open access

Vol 4, No 4 (2015)
Review articles (submitted)
Published online: 2015-10-16
Get Citation

Can incretin-based therapy and SGLT-2 inhibitors may be useful in the treatment of diabetes type 1?

Paulina Różańska, Bogna Wierusz-Wysocka, Dorota Zozulińska-Ziółkiewicz
DOI: 10.5603/DK.2015.0015
·
Diabetologia Kliniczna 2015;4(4):147-151.

open access

Vol 4, No 4 (2015)
Review articles (submitted)
Published online: 2015-10-16

Abstract

It is known, that insulin therapy is essential in the treatment of type 1 diabetes. Insulin therapy has been related with some side effects such as hypoglycemia and weight gain, strongly connected with insulin resistance. Therefore the metformin is used sometimes as additive therapy In patients with type 1 diabetes. Recently, glukagon-like peptide 1 (GLP-1) analogs, dipeptydyl peptidase 4 (DPP-4) inhibitors and sodium glucose co-transporter 2 inhibitors (SGLT-2) has been raported to be beneficial for the glycemic control in type 1 diabetic.

Abstract

It is known, that insulin therapy is essential in the treatment of type 1 diabetes. Insulin therapy has been related with some side effects such as hypoglycemia and weight gain, strongly connected with insulin resistance. Therefore the metformin is used sometimes as additive therapy In patients with type 1 diabetes. Recently, glukagon-like peptide 1 (GLP-1) analogs, dipeptydyl peptidase 4 (DPP-4) inhibitors and sodium glucose co-transporter 2 inhibitors (SGLT-2) has been raported to be beneficial for the glycemic control in type 1 diabetic.

Get Citation

Keywords

diabetes mellitus type 1, incretin-based therapy, SGLT-2 inhibitors

About this article
Title

Can incretin-based therapy and SGLT-2 inhibitors may be useful in the treatment of diabetes type 1?

Journal

Clinical Diabetology

Issue

Vol 4, No 4 (2015)

Pages

147-151

Published online

2015-10-16

DOI

10.5603/DK.2015.0015

Bibliographic record

Diabetologia Kliniczna 2015;4(4):147-151.

Keywords

diabetes mellitus type 1
incretin-based therapy
SGLT-2 inhibitors

Authors

Paulina Różańska
Bogna Wierusz-Wysocka
Dorota Zozulińska-Ziółkiewicz

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl